Awards will be offered by the National Institutes of Health and will be linked to grants currently held by the Institute of Translational Health Services and are open to: (1) students enrolled in doctoral programs at institutions of higher education in Washington, Wyoming, Alaska, Montana, and Idaho meeting T32/TL1 eligibility criteria, who can request 2 to 3 years of support for stipend and tuition, and (2) early career faculty and postdoctoral investigators meeting KL2 eligibility criteria, who can request support for 3 years of protected research time including salary and other support.
Gaize announces the launch of their real-time impairment screening device for cannabis and other drugs
Gaize, Inc. has announced the launch of their impairment screening solution for cannabis and other drugs. The product is a first-of-its-kind fully automated, non-invasive and portable eye movement test. It’s an objective way to detect the involuntary eye movement changes associated with impairment. Gaize recently completed the world’s largest cannabis impairment clinical trial, which validated the effectiveness of the product.
Make way to show kindness — Frederic Scheer, Alercell CEO
Frederic has been fighting cancer since 2017, when it was finally discovered, but it was not too early. He claims that as an entrepreneur he endured a series of health issues, but that these inspired him to launch Alercell, a company dedicated to the early detection of cancer. His new mission in life is to reform cancer detection practices at Alercell so that patients can avoid grueling treatment if the disease is detected at an early stage.
Alercell Launches Website Dedicated to New Cancer Detection Tests
Alercell has launched a new website—Lena Diagnostics, www.lenadx.com—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Experimental NIH Sudan Virus Vaccine Protects Macaques
A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.
Golden Helix — Enabling Precision Medicine
For over 20 years Golden Helix has been a software company that innovates genetic analysis software for next-generation sequencing (NGS) – and, believing that its customers and employees are at the heart of its success, it has built a glowing reputation as the industry leader in its field.
Inimmune outlines vaccine adjuvant work
Inimmune is a leader in the discovery and development of vaccine adjuvants with over 20 years of expertise in their safe and effective use.
Momentum continues in UM’s first year as “R1” research university
The University of Montana was named a top-tier “R1” research institution last year. It was the culmination of a decades-long goal for UM, and the science surge has only gained momentum in the first six months of the 2022-23 fiscal year.
Bitterroot College, Bitterroot Health partner on health care workforce
Health care is Montana’s largest industry and is projected to experience more job growth than any other industry in the state over the next eight years. However, with the State employment rate hovering around 2.6%, health care facilities are facing extreme workforce shortages. Because of this high demand for health care workers, Bitterroot Health and Bitterroot College are partnering to address these workforce issues through innovation and collaboration.